Swiss pharmaceutical giant Novartis will pay $28.1 billion for an additional 52 percent stake in Alcon, the worlds largest eye-care company.

The transaction is the second stage of a takeover announced in April 2008 when Novartis purchased from Nestlé S.A. 25 percent of the company for $10.4 billion (NYLJ, April 10, 2008).